ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO822

Impact of Delayed Graft Function on Kidney Transplant Outcomes

Session Information

Category: Transplantation

  • 2102 Transplantation: Clinical

Authors

  • Show, Mary, University of Michigan Michigan Medicine, Ann Arbor, Michigan, United States
  • Doshi, Mona D., University of Michigan Michigan Medicine, Ann Arbor, Michigan, United States
Background

Delayed graft function (DGF) is a frequent complication following deceased donor kidney transplant. The revised allocation policy mandates a wider geographical distribution of kidneys from deceased donors resulting in prolonged cold time and higher rates of DGF. Our study explores the impact of duration of DGF on graft function and survival.

Methods

We reviewed records of 687 patients who received deceased donor kidney transplant (DDKT) from 2020 to 2023 at the University of Michigan Transplant Center. Patients were grouped based on occurrence of DGF (need for dialysis within 7 days of transplant) and duration (0-14, 15-30, and >30 days). We compared donor, and recipient characteristics across 4 groups. Graft outcomes across 4 groups were compared via serum creatinine at last follow-up and also via Kaplan-Meier Survival Curves. Cox proportional hazard models were constructed to account for donor and recipient factors for graft loss.

Results

Of the 687 DDKT, 466 (68%) had no DGF and 221 (32%) developed DGF. Of 221 patients with DGF, 135 (61%) required dialysis for <14 days, 58 (26%) for 15-30 days, and 28 (13%) for more than 30 days. Donor risk factors that were associated with severe DGF include donation after cardiac death, death by anoxia, history of hypertension, and diabetes mellitus (p<0.05). Recipient risk factors for severe DGF include usage of anticoagulation, and Midodrine, African American race, and history of diabetes (p<0.05). Serum creatinine varied across 4 groups and was lowest among patients with no DGF and highest among patients with most severe DGF (1.1±0.6, 1.7±0.6, 2.3±0.9 and 2.4±1.4 mg/dL; p<0.001). Graft survival varied across 4 groups and was lowest among recipients requiring dialysis for more than 30 days (see Figure 1, p<0.001). On multi-variate analyses, severity of DGF, donor age and donor history of diabetes were associated with graft loss.

Conclusion

Duration of DGF has a negative impact on graft function and survival. New strategies are needed to improve organ preservation and manage patients after transplant to reduce the duration of DGF and subsequently graft loss.